Lv33
400 积分 2025-07-31 加入
Peripheral CD8+PD-1+ T cells as novel biomarker for neoadjuvant chemoimmunotherapy in humanized mice of non-small cell lung cancer
1天前
已完结
DSTYK Inhibition Sensitizes Non-Small Cell Lung Cancer To Taxane-Based Chemotherapy
1天前
已完结
Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer
1天前
已完结
The efficacy and safety of neoadjuvant immunochemotherapy in resectable stage I-III non-small cell lung cancer: a systematic review and network meta-analysis
2天前
已完结
AI‐guided histopathology predicts brain metastasis in lung cancer patients
8天前
已关闭
Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial
16天前
已完结
Grading of Tumor Regression in Non-small Cell Lung Cancer
18天前
已完结
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
27天前
已完结
Cancer immunotherapy using checkpoint blockade
29天前
已完结
Advances in immune neoadjuvant/adjuvant therapy‐related adverse events of non‐small cell lung cancer
30天前
已完结
皖公网安备34019202002308
